Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TXMDTXMD
Showing 7 of 11 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in THERAPEUTICSMD INC

CITADEL ADVISORS LLC holds 86,095 shares of TXMD (THERAPEUTICSMD INC), worth $190,270 as of 2026-Q2. The position was increased (+26.0% shares).

Current Value

$190,270

Current Shares

86,095

Total Value Change

+$190,270

Total Shares Change

+86,095

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
86,095
+26.0%
$190,2700.0%$2.21
19
2026-Q1
Increased
68,314
+141.9%
$137,9940.0%$2.22
24
2025-Q4
Decreased
28,240
-17.6%
$46,0310.0%$1.64
0
2025-Q3
New
34,273
-
$36,3290.0%$1.08
30
2025-Q1
Exited
0
-100.0%
$00.0%$0.98
0
2024-Q4
New
145,802
-
$125,4040.0%$1.03
34
2024-Q3
Exited
0
-100.0%
$00.0%$1.64
0

Other major holders of TXMD: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used